Skip to content

A Study on Frailty, Sarcopenia, and In-Hospital Activities of Daily Living Decline in Older Patients with Chronic Heart Failure in Japan and Korea

Impact of Combined Frailty and Sarcopenia on HAD and Short-Term Prognosis in Older Patients with Chronic Heart Failure: A Japan-Korea Multicenter Observational Study - J-K CHF Frailty-Sarcopenia Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000058192
Enrollment
240
Registered
2025-07-01
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Interventions

None listed

Sponsors

Wakayama Professional University of Rehabilitation
Lead Sponsor
Nagasaki University Hospital (Japan), Bucheon Sejong Hospital (Korea)
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 65 years or older who are admitted to a participating hospital in Japan or Korea due to chronic heart failure 2. Patients whose clinical condition has stabilized after acute treatment and who are deemed eligible for assessment by both the attending physician and physical therapist 3. Patients who are judged to be capable of undergoing frailty and sarcopenia assessments safely during hospitalization 4. Patients (or legal representatives) who provide written informed consent after receiving sufficient explanation of the study

Exclusion criteria

Exclusion criteria: 1. Patients for whom clinical assessment is deemed inappropriate due to acute myocardial infarction or other serious acute illnesses 2. Patients with severe dementia or impaired communication making it difficult to conduct evaluation or obtain informed consent 3. Patients with physical conditions that prevent the safe implementation of muscle function or basic mobility assessments

Design outcomes

Primary

MeasureTime frame
1. Prevalence of frailty in older patients with chronic heart failure in Japan and Korea 2. Prevalence of sarcopenia in the same population 3. Prevalence of coexisting frailty and sarcopenia 4. Incidence of hospital-associated disability(HAD) at the time of hospital discharge

Secondary

MeasureTime frame
1. Readmission rates within 30, 90, and 180 days after hospital discharge 2. Mortality rates within 30, 90, and 180 days after hospital discharge 3. Impact of coexisting frailty and sarcopenia on these readmission and mortality outcomes

Countries

Japan,Asia(except Japan)

Contacts

Public ContactHYUNJAE WOO

Wakayama Professional University of Rehabilitation Department of Physical Therapy

hyunjae0610@gmail.com0734354888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026